Phase 4 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have recently been diagnosed with ulcerative colitis (a condition causing inflammation of the large intestine)
- People whose ulcerative colitis is considered moderate to severe in how active or serious it is
- Children and teenagers between 6 and 18 years old
Who may not be able to join:
- People whose ulcerative colitis is considered mild in activity
- People who have already received steroid medications (such as cortisone or prednisone) or biologic drugs (a type of medication that targets the immune system) as treatment for their ulcerative colitis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ying Huang, Children's Hospital of Fudan University
Phone: 8615221881022
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mucosal healing rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.